Volume 1, Issue 4
Editorialp. 319-322
Facilitating use of Quality by Design concepts in regulatory submissions
Author(s): Patrick G Swann
News and Viewsp. 323-327
Decisional tool could influence future investment in cell therapy
Author(s): Alice O Hare
Special Interviewp. 329-331
Innovative cell factories for pharmaceutical production: focus on fungi
Author(s): Han AB Wosten
Commentaryp. 333-335
Scale-up and predictability in process development with suspension cultures of mammalian cells for recombinant protein manufacture: comments on a trend reversal
Author(s): Maria Joao De Jesus & Florian Maria Wurm*
Commentaryp. 337-339
Applications of genome-scale metabolic network models in the biopharmaceutical industry
Author(s): Hyun Uk Kim and Sang Yup Lee*
Special Issue Articlep. 341-349
Defining the implementation of single-use technology: a comparative evaluation of a single-use bioreactor with a stainless-steel bioreactor
Author(s): Geoffrey Blanc, Severine Leroy, Celine Leroy, Nicolas Gueraische, Cedric Borgne and Stephen Brown*
Short Reportp. 351-360
Trends regarding viral barrier implementation in animal cell culture processes
Author(s): Sean Delfosse, Melissa Sathavipat, Nathan Hsu, Matthew Croughan* and Michelle LaFond
Review Articlep. 361-372
The impact of continuous multicolumn chromatography on biomanufacturing efficiency
Author(s): Marc Bisschops* and Mark Brower
Review Articlep. 373-380
Comparability of biotherapeutics: characterization of protein vaccine antigens
Author(s): Marina Kirkitadze*,Arun Arunachalam and Bruce Carpick
Review Articlep. 381-404
Mass spectrometric analysis of protein species of biologics
Author(s): Richter, Kwiatkowski, Omidi, Omidi, Robertson & Schlutter
